Marvel Biosciences Corp. (TSXV:MRVL)
Canada · Delayed Price · Currency is CAD 0.1150
0.00 (0.00%)
Oct 9, 2026, 11:15 AM EST
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 8.49 million as of October 9, 2026. It is the 44,272nd most valuable company in the world and the 1,700th biggest in Canada. Its market cap has decreased by 36.98% in one year.
Market Cap
8.49M
Enterprise Value
9.45M
Revenue
n/a
Global Rank
Country Rank
#1,700 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 8.49M, a decrease of -33.22%. That is a compound annual growth rate of -7.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 8.49M | 8.38% |
| Dec 31, 2025 | 7.83M | 2.85% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PreveCeutical Medical | 12.76M |
| Rakovina Therapeutics | 11.15M |
| Britannia Life Sciences | 10.70M |
| COSCIENS Biopharma | 8.96M |
| Glow Lifetech | 7.70M |
| Kane Biotech | 6.15M |
| PharmaTher Holdings | 5.46M |
| MYND Life Sciences | 5.22M |